Andrew Reardon - Dec 29, 2023 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Role
CHIEF LEGAL OFFICER &
Signature
/s/ Andrew Reardon
Stock symbol
LGND
Transactions as of
Dec 29, 2023
Transactions value $
$10,867
Form type
4
Date filed
1/4/2024, 04:07 PM
Previous filing
Aug 14, 2023
Next filing
Feb 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Other $10.9K +179 +1.16% $60.71 15.6K Dec 29, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired under Ligand's employee stock purchase plan. Voluntary reporting exemption under Rule 16b-3(c).